.. Etude-moléculaire, Typage par séquençage multi-locus (MLST, multi-locus séquence typing), p.52

L. 'étude-des-rencontres-des-patients and .. , 59 2.3.1. Patients de la Souche 2, p.62

R. Etudes-des, Le mécanisme d'infection : Infection latente ou infection de novo ?, p.70

. Les-dates-d, infection pour les patients snt les suivantes : -Le patient 5 le 23/06/09, -le patient 6 le 10

M. Kumar, P. Cridge, and A. Molavi, Infectious complications in the first 100 days after renal transplantation, Transplant Proc, vol.27, pp.2705-2706, 1995.

J. Fishman, Infection in Solid-Organ Transplant Recipients, New England Journal of Medicine, vol.357, issue.25, pp.2601-2614, 2007.
DOI : 10.1056/NEJMra064928

G. Splendiani, S. Cipriani, and G. Tisone, Infectious Complications in Renal Transplant Recipients, Transplantation Proceedings, vol.37, issue.6, pp.2497-2499, 2005.
DOI : 10.1016/j.transproceed.2005.06.012

R. San-juan, J. Aguado, and C. Lumbreras, Incidence, Clinical Characteristics and Risk Factors of Late Infection in Solid Organ Transplant Recipients: Data from the RESITRA Study Group, American Journal of Transplantation, vol.67, issue.4, pp.964-971, 2007.
DOI : 10.1097/00007890-200205270-00013

J. Fishman and R. Rubin, Infection in Organ-Transplant Recipients, New England Journal of Medicine, vol.338, issue.24, p.338, 1998.
DOI : 10.1056/NEJM199806113382407

J. Fishman, Prevention of infection due to Pneumocystis carinii, Antimicrob Agents Chemother, vol.42, pp.995-1004, 1998.

. Gordon, Should Prophylaxis for Pneumocystis carinii Pneumonia in Solid Organ Transplant Recipients Ever Be Discontinued?, Clinical Infectious Diseases, vol.28, issue.2, pp.240-246, 1999.
DOI : 10.1086/515126

C. Chagas, Nouvelle espèce de trypanosomiase humaine, Bull. Soc. Pathol. Exot, vol.2, pp.304-307, 1909.

P. Delanoë and E. Delanoë, Sur des rapports de kystes de Carinii du poumon des rats et le Tryanosoma lewisi, C.R.Acad.Sci, vol.155, pp.658-660, 1912.

C. Creusy, J. Bahon-le-capon, L. Fleurisse, C. Mullet, M. Dridba et al., Pneumocystis carinii Pneumonia in Four Mammal Species: Histopathology and Ultrastructure, The Journal of Eukaryotic Microbiology, vol.41, issue.5, pp.47-55, 1996.
DOI : 10.1007/BF00931702

E. Dei-cas, Pneumocystis infections: the iceberg?, Medical Mycology, vol.96, issue.s1, pp.23-32, 2000.
DOI : 10.1073/pnas.96.5.2402

A. Wakefield, J. Stringer, E. Tamburrini, and E. Dei-cas, Genetics, metabolism and host specificity of Pneumocystis carinii, Med Mycol, vol.36, pp.183-93, 1998.

F. Gigliotti, A. Harmsen, C. Haidaris, and P. Haidaris, Pneumocystis carinii is not universally transmissible between mammalian species, Infect Immun, vol.61, pp.2886-90, 1993.

E. Aliouat, E. Mazars, and E. Dei-cas, Pneumocystis cross infection experiments using SCID mice and nude rats as recipient host, showed strong host-species specificity, J Eukaryot Microbiol, 1994.

E. Dei-cas, M. Brun-pascaud, V. Bille-hansen, A. Allaert, and E. Aliouat, XX. Animal models of pneumocystosis, FEMS Immunology & Medical Microbiology, vol.12, issue.1-2, pp.163-171, 1998.
DOI : 10.1093/infdis/175.3.655

C. Aliouat-denis, M. Chabé, and C. Demanche, Pneumocystis species, co-evolution and pathogenic power, Infection, Genetics and Evolution, vol.8, issue.5, pp.708-726, 2008.
DOI : 10.1016/j.meegid.2008.05.001

G. Van-der-meer and S. Brug, Infection à pneumocysits chez l'homme et les animaux

J. Vanek, O. Jirovec, and J. Lukes, Interstitial plasam cell pneumonia in infants, Annales Paediatrici, vol.180, pp.1-21, 1953.

K. Sepkowitz, Opportunistic Infections in Patients with and Patients without Acquired Immunodeficiency Syndrome, Clinical Infectious Diseases, vol.28, issue.8, pp.1098-107, 2002.
DOI : 10.1086/322663

J. Kovacs and H. Masur, Evolving Health Effects of Pneumocystis, JAMA, vol.301, issue.24, pp.2578-85, 2009.
DOI : 10.1001/jama.2009.880

S. Yale and A. Limper, Pneumocystis carinii Pneumonia in Patients Without Acquired Immunodeficiency Syndrome: Associated Illnesses and Prior Corticosteroid Therapy, Mayo Clinic Proceedings, vol.71, issue.1, pp.5-13, 1996.
DOI : 10.4065/71.1.5

F. Roblot, C. Godet, and C. Kauffmann, Facteurs favorisants de la pneumocystose (PPC) chez les malades immunod??prim??s non infect??s par le VIH, Journal de Mycologie M??dicale, vol.19, issue.4, pp.285-289, 2009.
DOI : 10.1016/j.mycmed.2009.09.005

J. Hamburger, J. Crosmer, and J. Dormont, EXPERIENCE WITH 45 RENAL HOMOTRANSPLANTATIONS IN MAN, The Lancet, vol.285, issue.7393, pp.985-992, 1965.
DOI : 10.1016/S0140-6736(65)91218-3

D. Rifkind, T. Starlz, T. Marchioro, W. Waddell, D. Rowlands et al., Transplantation Pneumonia, JAMA, vol.189, issue.11, pp.808-812, 1964.
DOI : 10.1001/jama.1964.03070110010002

D. Rifkind, D. Tandus, . Faris, and B. Rolla, Pneumonia, Annals of Internal Medicine, vol.65, issue.5, pp.943-56, 1966.
DOI : 10.7326/0003-4819-65-5-943

A. Hardy, C. Wajszczuk, A. Suffredini, T. Hakala, and M. Ho, Pneumocystis carinii Pneumonia in Renal-Transplant Recipients Treated with Cyclosporine and Steroids, Journal of Infectious Diseases, vol.149, issue.2, pp.143-147, 1984.
DOI : 10.1093/infdis/149.2.143

A. Branten, P. Beckers, R. Tiggeler, and A. Hoitsma, Pneumocystis carinii pneumonia in renal transplant recipients, Nephrol Dial Transplant, vol.10, pp.1194-1197, 1995.

V. Lufft, V. Kliem, M. Behrend, R. Pichlmayr, K. Koch et al., INCIDENCE OF Pneumocystis carinii PNEUMONIA AFTER RENAL TRANSPLANTATION, Transplantation, vol.62, issue.3, pp.421-423, 1996.
DOI : 10.1097/00007890-199608150-00022

M. Radisic, R. Lattes, J. Chapman, M. Del-carmen-rial, O. Guardia et al., Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study, Transplant Infectious Disease, vol.5, issue.2, pp.84-93, 2003.
DOI : 10.1034/j.1399-3062.2003.00018.x

M. Rodriguez and J. Fishman, Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients, Clinical Microbiology Reviews, vol.17, issue.4, pp.770-782, 2004.
DOI : 10.1128/CMR.17.4.770-782.2004

D. Magne, A. Angoulvant, and F. Botterel, Réseau pneumcystose francilien : bilan de cinq années de surveillance, pp.290-293, 2003.
DOI : 10.1016/j.mycmed.2009.05.002

M. Rabodonirina, P. Vanhems, and S. Couray-targe, Molecular Evidence of InterhumanTransmission of PneumocystisPneumonia among Renal Transplant Recipients Hospitalized with HIV-Infected Patients, Emerging Infectious Diseases, vol.10, pp.1766-1773, 2004.

F. Eitner, I. A. Hauser, and O. Rettkowski, Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients, Nephrology Dialysis Transplantation, vol.23, issue.2, pp.2013-2017, 2011.
DOI : 10.1093/ndt/gfn161

D. Boer, M. G. Bruijnesteijn-van-coppenraet, L. E. Gaasbeek, and A. , An Outbreak of Pneumocystis jiroveci Pneumonia with 1 Predominant Genotype among Renal Transplant Recipients: Interhuman Transmission or a Common Environmental Source?, Clinical Infectious Diseases, vol.33, issue.4, pp.1143-1152, 2007.
DOI : 10.1080/003655401300077324

S. Gianella, L. Haeberli, and B. Joos, pneumonia among renal transplant recipients, Transplant Infectious Disease, vol.12, issue.1, pp.1-10, 2010.
DOI : 10.1111/j.1399-3062.2009.00447.x

S. Thomas, R. Vivancos, and C. Corless, Increasing Frequency of Pneumocystis jirovecii Pneumonia in Renal Transplant Recipients in the United Kingdom: Clonal Variability, Clusters, and Geographic Location, Clinical Infectious Diseases, vol.35, issue.12, pp.307-308, 2011.
DOI : 10.1111/j.1600-6143.2009.02655.x

J. Shelhamer, Respiratory Disease in the Immunosuppressed Patient, Annals of Internal Medicine, vol.117, issue.5, pp.415-431, 1992.
DOI : 10.7326/0003-4819-117-5-415

A. Schaffner, Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon., Journal of Clinical Investigation, vol.76, issue.5, pp.1755-64, 1985.
DOI : 10.1172/JCI112166

M. S. Fishman and J. A. , Pneumocystis Pneumonia in Solid Organ Transplant, American Journal of Transplantation, vol.9, issue.suppl4, pp.227-233, 2009.

A. Roux, V. Lemiale, and A. Kouatchet, Pneumocystose pulmonaire en dehors de l???infection ?? VIH, R??animation, vol.19, issue.4, pp.327-338, 2010.
DOI : 10.1016/j.reaurg.2010.04.002

J. Ribes, A. Limper, and M. Espy, PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity, J Clin Microbiol, vol.35, issue.4, pp.830-835, 1997.

G. Bollee, C. Sarfati, and G. Thiery, Clinical Picture of Pneumocystis jiroveci Pneumonia in Cancer Patients, Chest, vol.132, issue.4, pp.1305-1315, 2007.
DOI : 10.1378/chest.07-0223

E. Azoulay, D. Mokart, and A. Rabbat, Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: Prospective multicenter data*, Critical Care Medicine, vol.36, issue.1, pp.100-107, 2008.
DOI : 10.1097/01.CCM.0000295590.33145.C4

A. Sing, K. Trebesius, and A. Roggenkamp, Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups, J Clin Microbiol, vol.38, issue.4, pp.1461-1468, 2000.

J. Kovacs, V. Ng, and H. Masur, Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies, N Engl J Med, issue.10, pp.318-589, 1988.

A. Wakefield, L. Guiver, and R. Miller, DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumonia, The Lancet, vol.337, issue.8754, pp.1378-1387, 1991.
DOI : 10.1016/0140-6736(91)93062-E

T. Leigh, B. Gazzard, and A. Rowbottom, Quantitative and qualitative comparison of DNA amplification by PCR with immunofluorescence staining for diagnosis of Pneumocystis carinii pneumonia., Journal of Clinical Pathology, vol.46, issue.2, pp.140-144, 1993.
DOI : 10.1136/jcp.46.2.140

E. Azoulay, A. Bergeron, and S. Chevret, Polymerase Chain Reaction for Diagnosing Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients With Pulmonary Infiltrates, Chest, vol.135, issue.3, pp.655-61, 2009.
DOI : 10.1378/chest.08-1309

URL : https://hal.archives-ouvertes.fr/inserm-00448960

. Arend, Rejection Treatment and Cytomegalovirus Infection as Risk Factors for Pneumocystis carinii Pneumonia in Renal Transplant Recipients, Clinical Infectious Diseases, vol.22, issue.6, pp.920-925, 1996.
DOI : 10.1093/clinids/22.6.920

C. Thomas, . Jr, and A. Limper, Pneumocystis Pneumonia, New England Journal of Medicine, vol.350, issue.24, pp.2487-98, 2004.
DOI : 10.1056/NEJMra032588

B. Spratt, Multilocus sequence typing: molecular typing of bacterial pathogens in an era of rapid DNA sequencing and the Internet, Current Opinion in Microbiology, vol.2, issue.3, pp.312-318, 1999.
DOI : 10.1016/S1369-5274(99)80054-X

M. Bougnoux, S. Morand, D. Enfert, and C. , Usefulness of Multilocus Sequence Typing for Characterization of Clinical Isolates of Candida albicans, Journal of Clinical Microbiology, vol.40, issue.4, pp.1290-1297, 2002.
DOI : 10.1128/JCM.40.4.1290-1297.2002

R. Urwin and M. Maiden, Multi-locus sequence typing: a tool for global epidemiology, Trends in Microbiology, vol.11, issue.10
DOI : 10.1016/j.tim.2003.08.006

D. Kumar, S. Gourishankar, and T. Mueller, pneumonia after rituximab therapy for antibody-mediated rejection in a renal transplant recipient, Transplant Infectious Disease, vol.11, issue.2, pp.167-170, 2009.
DOI : 10.1111/j.1399-3062.2008.00345.x

E. Shelton, M. Yong, and S. Cohney, Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection, Nephrology, vol.176, issue.7, pp.696-699, 2009.
DOI : 10.4049/jimmunol.176.10.6147

J. A. Fishman, Prevention of infections caused by Pneumocystis carinii in transplant recipients, Clin Infect Dis, vol.33, pp.1937-1405, 2001.

A. Morris, C. Beard, and L. Huang, Infection à pneumocystis chez l'homme et les animaux, Microbes Infect, vol.22, pp.301-307, 2002.

W. Chen, F. Gigliotti, and A. Harmsen, Latency is not an inevitable outcome of infection with Pneumocystis carinii, Infect Immun, vol.61, pp.5406-5415, 1993.

P. Roux, I. Lavrard, J. Poirot, C. Chouaid, M. Denis et al., Usefulness of PCP for detection of Pneumocystis carinii DNA, J Clin Microbial, vol.32, pp.2324-2330, 1994.

S. Peters, A. Wakefield, K. Sinclair, P. Millard, and J. Hopkin, A search forPneumocystis carinii in post-mortem lungs by DNA amplification, The Journal of Pathology, vol.5, issue.2, pp.195-203, 1992.
DOI : 10.1093/infdis/136.1.43

G. Nevez, E. Magois, H. Duwat, V. Gouilleux, V. Jounieaux et al., Apparent Absence of Pneumocystis jirovecii in Healthy Subjects, Clinical Infectious Diseases, vol.10, issue.7, pp.99-101, 2006.
DOI : 10.1111/j.1469-0691.2004.00921.x

URL : https://hal.archives-ouvertes.fr/hal-00559705

S. Keely, R. Baughman, A. Smulian, M. Dohn, and J. Stringer, Source of pneumocystis carinii in recurrent episodes of pneumonia in AIDS patient, AIDS, vol.10, issue.8, pp.881-889, 1996.
DOI : 10.1097/00002030-199607000-00011

S. Schmoldt, R. Schuhegger, and T. Wendler, Molecular Evidence of Nosocomial Pneumocystis jirovecii Transmission among 16 Patients after Kidney Transplantation, Journal of Clinical Microbiology, vol.46, issue.3, pp.966-971, 2008.
DOI : 10.1128/JCM.02016-07

A. Totet, S. Latouche, P. Lacube, J. Pautard, V. Jounieaux et al., Dihydropteroate Synthase Genotypes in Immunocompetent Infants and Immunosuppressed Adults, Amiens, France, Emerging Infectious Diseases, vol.10, issue.4, pp.667-73, 2004.
DOI : 10.3201/eid1004.030451

A. Dumoulin, E. Mazars, and N. Seguy, Transmission of Pneumocystis carinii ??? Disease from Immunocompetent Contacts of Infected Hosts to Susceptible Hosts, European Journal of Clinical Microbiology & Infectious Diseases, vol.19, issue.9, pp.671-678, 2000.
DOI : 10.1007/s100960000354

R. Miller, H. Ambrose, and A. Wakefield, Pneumocystis carinii f. sp. hominis DNA in Immunocompetent Health Care Workers in Contact with Patients with P. carinii Pneumonia, Journal of Clinical Microbiology, vol.39, issue.11, pp.3877-82, 2001.
DOI : 10.1128/JCM.39.11.3877-3882.2001

M. Chabé, E. Dei-cas, and C. Creusy, Immunocompetent Hosts as a Reservoir of Pneumocystis Organisms:Histological and RT-PCR Data Demonstrate Active Replication, Eur J Clin Microbiol Infect Dis, vol.23, pp.89-97, 2004.

G. Nevez, A. Totet, V. Jounieaux, J. Schmit, E. Dei-cas et al., Pneumocystis jiroveci Internal Transcribed Spacer Types in Patients Colonized by the Fungus and in Patients with Pneumocystosis from the Same French Geographic Region, Journal of Clinical Microbiology, vol.41, issue.1, pp.181-187, 2003.
DOI : 10.1128/JCM.41.1.181-186.2003

C. Armbruster, A. Hassl, and S. Kriwanek, Pneumocystis carinii Colonization in the Absence of Immunosuppression, Scandinavian Journal of Infectious Diseases, vol.34, issue.41, pp.591-594, 1997.
DOI : 10.3322/canjclin.46.5.303

M. Probst, H. Ries, T. Schmidt-wieland, and A. Serr, Detection of Pneumocystis carinii DNA in Patients with Chronic Lung Diseases, European Journal of Clinical Microbiology & Infectious Diseases, vol.19, issue.8, pp.644-649, 2000.
DOI : 10.1007/s100960000329

G. Nevez, C. Raccurt, and P. Vincent, Pulmonary Colonization with Pneumocystis cariniiin Human Immunodeficiency Virus-Negative Patients: Assessing Risk with Blood CD4+ T Cell Counts, Clinical Infectious Diseases, vol.35, issue.11, pp.1331-1333, 1999.
DOI : 10.1111/j.1550-7408.1996.tb04965.x

L. Casanova-cardiel and M. Leibowitz, Presence of Pneumocystis carinii DNA in Pond Water., The Journal of Eukaryotic Microbiology, vol.34, issue.s6, p.28, 1997.
DOI : 10.1016/0166-6851(90)90131-5

A. Wakefield, DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora, J Clin Microbiol, vol.34, pp.1754-1763, 1996.

M. Bartlett, C. Lee, J. Lu, N. Bauer, J. Bettz et al., Pneumocystis carinii detected in air, J Eukaryot Microbiol, vol.41, p.75, 1994.

S. Latouche, A. Totet, P. Lacube, J. Bolognini, G. Nevez et al., Development of an RT-PCR on the Heat Shock Protein 70 Gene for Viability Detection of Pneumocystis carinii f. sp. hominis in Patients with Pneumocystosis and in Air Sample, Journal of Eukaryotic Microbiology, vol.336, pp.176-183, 2001.
DOI : 10.1111/j.1550-7408.2001.tb00508.x

N. Mansharamani, R. Garland, D. Delaney, and H. Koziel, Management and Outcome Patterns for Adult Pneumocystis carinii Pneumonia, 1985 to 1995, Chest, vol.118, issue.3, pp.704-715, 1985.
DOI : 10.1378/chest.118.3.704

P. Deteix, M. Mojon, J. Garin, N. Revillard, J. Traeger et al., Pneumopathies à pneumocystis carinii après transplantation rénale, Lyon medical, vol.232, issue.13, pp.37-47, 1974.

W. T. Hughes, S. Khun, and S. Chaudhary, Pneumonitis, New England Journal of Medicine, vol.297, issue.26, pp.1419-1426, 1997.
DOI : 10.1056/NEJM197712292972602

. Fox, A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: Clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis, The American Journal of Medicine, vol.89, issue.3, pp.255-274, 1990.
DOI : 10.1016/0002-9343(90)90337-D

S. Arend and J. Van-'t-wout, Editorial Response: Prophylaxis for Pneumocystis carinii Pneumonia in Solid Organ Transplant Recipients???As Long as the Pros Outweigh the Cons, Clinical Infectious Diseases, vol.28, issue.2, pp.247-256, 1999.
DOI : 10.1086/514542

R. Higgins, S. Bloom, J. Hopkin, and P. Morris, The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis carini pneumonia in renal transplantation, Transplantation, vol.47, pp.558-60, 1989.

H. Green, M. Paul, L. Vidal, and L. Leibovici, Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials, Mayo Clinic Proceedings, vol.82, issue.9, pp.1052-1059, 2007.
DOI : 10.4065/82.9.1052

N. Mansharamani, D. Balachandran, I. Vernovsky, R. Garland, and H. Koziel, Peripheral Blood CD4 + T-Lymphocyte Counts During Pneumocystis carinii Pneumonia in Immunocompromised Patients Without HIV Infection, Chest, vol.118, issue.3, pp.712-732, 2000.
DOI : 10.1378/chest.118.3.712

K. Sepkowitz, A. Brown, and D. Armstrong, Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk, Archives of Internal Medicine, vol.155, issue.11, pp.1125-1133, 1995.
DOI : 10.1001/archinte.155.11.1125

H. Masur, Prevention and treatment of pneumocystis pneumonia, N Engl J Med, vol.327, issue.26, pp.1853-60, 1992.

C. Colby, A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation, Bone Marrow Transplantation, vol.24, issue.8, pp.897-902, 1999.
DOI : 10.1038/sj.bmt.1702004